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(+)-Discodermolide binds to m icrotubules in stoichiometric 
ratio to tubulin dimers, blocks taxol binding and results in 
m itotic arrest 
Deborah T Hung*, Jie Chen* and Stuart L Schreiber 
Bawround: The marine natural product (+)-discodermolide has potent 
immunosuppressive activity. It inhibits proliferation of a wide range of human and 
murine cells, induces cell cycle arrest in the G2 or M  phase and was recently shown 
to stabilize microtubules. Total synthesis of discodermolide has made it possible to 
generate variants of the compound to study its intracellular function in detail. 
Results: We have determined that (+)-discodermolide arrests MG63 cells at M  
phase, and has a stabilizing effect on microtubules. In vitro studies show that 
discodermolide induces polymerization of purified tubulin in the absence of 
microtubule-associated proteins, and that it binds to tubulin dimers in 
microtubules at 1 :l stoichiometry. Discodermolide binds taxol-polymerized 
microtubules at near stoichiometric level, whereas taxol binds discodermolide- 
induced microtubules poorly. Competition data show that the binding of 
microtubules by discodermolide and taxol are mutually exclusive; discodermolide 
binds with higher affinity than taxol. The results of binding assays carried out in 
V&O or in cell lysates also suggest that the microtubule network is 
discodermolide’s cellular target. 
Condusions: (+)-Discodermolide causes cell cycle arrest at the 
metaphase-anaphase transition in mitosis, presumably due to its stabilizing effect 
on microtubules. In vitro, discodermolide polymerizes purified tubulin potently in the 
absence of MAPS.  It binds microtubules at one molecule per tubulin dimer with a 
higher affinity than taxol, and the binding of microtubules by discodermolide and 
taxol are mutually exclusive. In total cell lysates discodermolide displays binding 
activity that is consistent with its effects on microtubules. 
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Introduction 
Lipophilic natural products that penetrate the plasma 
membrane of cells and interfere with cellular functions can 
serve as excellent tools for probing intracellular signal 
transduction pathways. The marine natural product 
(+)-discodermolide, originally isolated from the sponge 
Discodermia dissoha, is a promising candidate for this 
purpose. Discodermolide is immunosuppressive; it has an 
IC,, of 9 nM for inhibition of purified murine T cell 
proliferation, inhibits the mixed leukocyte reaction, and 
suppresses graft-versus-host disease in transplanted mice 
[1,2]. Recently, this compound has also been shown to 
cause cell cycle arrest in the gap 2 (GZ) or mitosis (M) phase 
in a variety of human and murine cell lines, with IC,, 
values ranging from 3 nM to 80 nM [3,4]. The exact arrest 
point and the mechanism of arrest are not known, however. 
Total syntheses of both (+)- and (-)-discodermolide have 
been accomplished [3,5], and it is now possible to make 
discodermolide derivatives to probe the target of its action. 
To understand the mechanism of discodermolide’s action 
better, we have investigated its cellular effects in detail. 
We initiated the characterization of discodermolide’s cell- 
ular target using tritiated discodermolide, and identified a 
cellular binding activity [3]. Here we report that disco- 
dermolide arrests cells at a stage after entering mitosis. 
Entry into, and exit from, the M  phase of the cell cycle is 
controlled by the synthesis and degradation of M-phase- 
promoting factor (MPF). Cyclin B is an essential 
component of MPF, and its synthesis and degradation are 
an important part of the control of MPF activity. Here we 
show that prolonged cyclin B expression is observed in the 
presence of discodermolide, and that treated cells 
eventually exit mitosis with micronucleated nuclei. 
Abnormal microtubule formation is observed in disco- 
dermolide-treated cells. The microtubules form concen- 
trated bundles instead of the normal network and show 
increased stability against cold-induced depolymerization. 
These results indicate that discodermolide may have a 
direct effect on microtubules, consistent with the recent 
report that discodermolide stabilizes microtubules in 
breast cancer cells [6]. In accordance with these 
observations, fractionation of cells treated with [3H]disco- 
dermolide and lysed with non-ionic detergent shows that 
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over 90 %  of radioactivity is associated with cell pellets, 
which include nuclei and cytoskeletons. Since the mitotic 
spindle, which is composed of microtubules, is essential 
for M  phase progression of the cell cycle, our results 
strongly suggest that discodermolide arrests cells at M  
phase by causing aberrant spindle formation. 
This effect of discodermolide on microtubules is remi- 
niscent of the effect of taxol, which has been reported to 
polymerize, bind and stabilize microtubules [7-91. We 
therefore examined the effect of discodermolide on 
purified tubulin in vitro. Indeed, discodermolide poly- 
merizes tubulin into microtubules in the absence of 
microtubule-associated proteins (MAPS) and binds to 
microtubules at one molecule per tubulin dimer. Disco- 
dermolide binds either to the same site on microtubules as 
taxol or to an overlapping site, and has a significantly 
higher affinity for its site than does taxol. 
Results 
Discodermolide arrests cells in mitosis 
Discodermolide has previously been shown by flow 
cytometry to arrest MG63 human osteosarcoma cells [3] 
and murine Doll.10 T hybridoma cells [4] at G2 or M  
phase. To define the arresting mechanism further, we 
examined the effect of discodermolide on cyclin B 
expression. In a variety of eukaryotic cells, expression of 
cyclin B and its subsequent association with and activation 
of cdc2 kinase result in active MPF, which drives the cell 
cycle into mitosis [lO-1’21. Degradation of cyclin B and the 
resulting inactivation of MPF occur at anaphase of mitosis, 
followed by sister chromatid segregation, chromosome 
decondensation, cytokinesis, and nuclear envelope refor- 
mation [13-151. MG63 cells synchronized at the Gl/S 
boundary by hydroxyurea, an inhibitor of ribonucleotide 
reductase, were released from the block by removing 
hydroxyurea and incubated in the presence or absence of 
100 nM discodermolide. Cyclin Bl expression was 
examined by lysing the cells at different time points and 
subjecting the lysates to Western analysis. As shown in 
Figure 1, discodermolide treatment did not affect the 
onset of cyclin Bl expression. The subsequent degrad- 
ation of cyclin Bl was delayed by -6-12 h in the presence 
of discodermolide, however. A similar delay was observed 
when serum-starved cells were synchronized at GO (a 
quiescent state outside the normal cell cycle) and stim- 
ulated to re-enter the cell cycle (data not shown). The 
discodermolide-treated cells had a morphology charact- 
eristic of mitotic cells (detached and rounded) during the 
prolonged period of cyclin Bl expression, and re-adhered 
when cyclin Bl eventually dropped to basal level. The re- 
adhered cells, however, were mostly micronucleated and 
often larger in size than the control cells (see Fig. Zc,d). 
During the preparation of this manuscript, ter Haar et a/. 
[6] reported that discodermolide arrests Burkitt lymphoma 
CA46 cells at mitosis, determined by mitotic index. Our 
Figure 1 
Discodermolide delays the degradation of cyclin B. MG63 cells 
synchronized at S  phase by 2 m M  hydroxyurea were released into the 
ceil cycle in the absence or presence of 100 nM discodermolide. 
Cyclin B  expression at O-30 h after the release was analyzed by 
Western blotting with anti-human cyclin Bl antibody. 
observations using hydroxyurea-released MG63 cells 
confirm and extend their findings. 
Discodermolide stabilizes microtubules in viva 
Almost all anti-mitotic reagents interact with microtubules. 
Classic examples include colchicine and colcemid, both 
microtubule-destabilizing reagents [ 161, and taxol, a 
microtubule-stabilizing drug [7-91. These molecules arrest 
or prolong the cell cycle at the metaphase-anaphase 
transition of mitosis, and cells that eventually escape the 
block are mostly micronucleated. These observations 
therefore prompted us to examine the effect of disco- 
dermolide on microtubules. Asynchronous Swiss 3T3 cells 
treated with 100 nM or 1 ~.LM discodermolide for 24-36 h 
were stained using anti-tubulin antibodies. Instead of the 
continuous network of microtubules seen in control cells, 
discodermolide-treated cells contained dense and discon- 
tinuous bundles of microtubules, mostly concentrated 
around the nucleus or edges of the cell (Fig. Z), whereas 
taxol-treated cells displayed an abnormally dense network 
of microtubules. The staining pattern of discodermolide- 
treated cells was independent of the phase of the cell cycle 
(data not shown). 
We also examined the effect of discodermolide on the 
stability of microtubules upon cold treatment in vivo. 
Whereas the microtubule network in control Swiss 3T3 
cells disappeared completely upon incubation at 4 “C for 
16 h (Fig. Zk), discodermolide preserved microtubules 
even better than taxol (Fig. Zi,j), although in all cases cells 
were considerably diminished in size. We therefore 
conclude that discodermolide, like taxol, acts to stabilize 
microtubules in vivo. 
Discodermolide binds to microtubules in vifro 
Since taxol induces tubulin polymerization in vitro [8], we 
next investigated the effect of discodermolide on purified 
tubulins. In the absence of microtubule-associated 
proteins (MAPS), which are normally required for tubulin 
polymerization in vitro, 10 ~.LM discodermolide alone 
rapidly induced polymerization of tubulin at 37 “C (data 
not shown). This is consistent with the results of ter Haar 
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Figure 2 
Effects of discodermolide on microtubules in cells. In panels (a)-(h), 
asynchronous Swiss 3T3 cells were treated with discodermolide or 
taxol for 38 h before fixing and staining as described in Materials and 
methods. In panels (i)-(k), cells were treated with drugs for 24 h at 
37 “C, then incubated at 0 “C for 16 h. Panels (a)-(d) show views from 
microscope light field, while panels (e)-(k) are from fluorescent field. 
Green, microtubules; red, DNA. (a), (e), (i) control, (b), (f), (i) 100 nM 
taxol, (c), (g), (k) 100 nM discodermolide, (d), (h) 1 PM 
discodermolide. All micrographs are shown at the same magnification. 
et al. [6], who further showed that discodermolide 
polymerizes tubulin more potently than taxol at 0 “C or in 
the absence of MAPS and GTP 
We then studied the binding of tritiated discodermolide to 
microtubules. Pure tubulins (10 FM dimer, containing no 
MAPS) were polymerized by 10 pM taxol in the presence 
of 1 mM GTP at 37 “C for 30 min, then incubated with 
various concentrations of [3H]discodermolide. Binding was 
assessed by sedimenting microtubules and determining 
radioactivity in the pellet by scintillation counting. Data 
presented in Table 1 show that the binding to 10 pM 
tubulin is saturated by 10 FM discodermolide, indicating a 
binding stoichiometry of one discodermolide per tubulin 
dimer. Under the above conditions, essentially all the 
tubulin dimers are occupied with taxol prior to the addition 
of discodermolide. Therefore, discodermolide must be 
binding to the same tubulin dimers that originally bound to 
taxol. These results did not determine whether disco- 
dermolide competes with taxol for binding to microtubules, 
however; discodermolide could bind at a site distinct from 
that for taxol, or to the same site but with a higher affinity. 
There is no obvious structural similarity between taxol and 
discodermolide (Fig. 3a), and therefore no apriori reason to 
suspect that they would bind to the same site. 
To determine whether taxol and discodermolide bind to 
the same or overlapping sites on microtubules, we per- 
formed several competition binding experiments. Tubulin 
(10 pM) was polymerized in the presence of 10 pM 
radiolabeled taxol (Fig. 3b) or discodermolide (Fig. 3c), 
and then various concentrations of unlabeled competitor 
were added. At the end of the incubation, the radioactivity 
Table 1 
Stoichiometry of discodermolide binding to taxol- 
polymerized tubulin. 
[discodermolideI:[tubulinl Fractional saturation 
of binding 
0.1 0.113 f 0.004 
0.5 0.563 f 0.016 
1 0.994 f 0.070 
2 0.997 + 0.062 
5 1 .ooo + 0.070 
Pure tubulin (10 )LM dimer) was polymeriied in the presence of 10 PM 
taxol and 1 mM GTP at 37 “C for 30 min. [3H]discodermolide was then 
added at 1 PM, 5 PM, 10 PM, 20 PM and 50 PM, respectively, and 
incubated at 37 “C for 30 min, followed by sedimentation and 
scintillation counting of the pellets. Fractional saturation of binding was 
calculated as the ratio of counts at each discodermolide concentration 
versus counts at saturating concentrations. 
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Competition of discodermolide and taxol binding of microtubules. 
(a) Discodermolide and taxol show no obvious structural similarity. 
(b) Purified tubulin (10 F M  dimer) was polymerized in P E M  buffer 
containing 1 m M  GTP and 10 P M  PH]taxol or (c) 10 F M  
F’Hldiscodermolide. After incubation with various concentrations of 
drugs (competitors), microtubule-bound radioactivities were measured. 
Black bars, discodermolide as competitor; blue bars, taxol as 
competitor. Relative binding is defined as the percentage of binding in 
the presence of competitors relative to binding in the absence of 
competitors. Average of the data from at least three independent 
experiments are presented. Error bars indicate standard deviations. 
remaining bound to the microtubules was counted. As [3]. To test whether this in v&o binding target corresponds 
shown in Figure 3, discodermolide is a more effective to its in vitro effect, we crudely fractionated the cells that 
competitor for [3H]taxol binding than taxol itself, and taxol were treated in vivo with 20 nM [3H]discodermolide by 
was not able to compete effectively with [3H]disco- lysing the cells with non-ionic detergents (e.g., 1 %  Triton 
dermolide, even at higher concentrations (50 PM). Both X-100); the binding activity in the soluble fraction 
discodermolide and taxol competed with themselves as (containing cytoplasmic and membrane proteins) was 
expected, showing -50% competition at a concentration of precipitated by polyethylene glycol (PEG), and compared 
lOp,M. Therefore, discodermolide and taxol bind to to the bound activity in the insoluble fraction (containing 
mutually exclusive sites on microtubules, and disco- nuclei and cytoskeletons). Over 90 %  of bound radioactivity 
dermolide has higher affinity than taxol. When competition was found in the insoluble fraction, which included the 
experiments were carried out for taxol versus taxotere by majority of microtubules. Co-treatment of the cells with 
Diaz and Andreu [17], it was observed that taxotere colchicine, which disrupts microtubules, abolished the 
competed with taxol for the same binding site with 1.9 binding activity (Fig. 4a), indicating that the intact 
times higher affinity, consistent with the fact that these two microtubule network was the binding target. This is consis- 
compounds are structurally related. In this case, binding is tent with the observed in vitro binding of discodermolide 
competitive in the absence of obvious structural similarity. to microtubules. 
In viva target of discodermolide The cellular discodermolide-binding activity seems highly 
Previously we have shown that a specific binding activity unstable under the lysis conditions, if the cells are lysed 
for [3H]discodermolide is present in MG63 cell total lysates before discodermolide treatment. When the cells were 
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lysed prior to addition of [3H]discodermolide, very low 
binding activity was observed (Fig. 4b). Strikingly, when 
taxol (ZOO nM) was added at the time of lysis, binding 
activity comparable to the in vivo activity was observed 
and, again, at least 90 % of the binding activity was in the 
insoluble fraction (Fig. 4b). One possible explanation for 
this observation is that discodermolide does not effectively 
polymerize tubulins at the low concentration used for the 
assay, and that a pre-existing intact microtubule network is 
required for it to bind. Tax01 serves to stabilize the 
microtubules, preserving the discodermolide binding site. 
Discussion 
We have established that discodermolide has an effect on 
microtubules both in vivo and in vitro. Cells treated with 
discodermolide display abnormally intense staining of 
microtubule bundles that are cold-resistant (Fig. 2). In 
vitro, discodermolide potently induces the polymerization 
of purified tubulin in the absence of MAPS. During the 
preparation of this manuscript, ter Haar et a/. [6] reported 
similar observations; consistent with our data, they have 
shown that discodermolide potently induces tubulin 
polymerization at 0 “C, or in the absence of both MAPS 
and GTP, conditions where taxol at an identical 
concentration has very little effect. Using radiolabeled 
discodermolide, we have further shown that this molecule 
binds to purified microtubules with an affinity that is 
higher than that of taxol. Despite the lack of structural 
similarities, the binding of discodermolide and taxol to 
microtubules is mutually exclusive (Fig. 3). It is possible 
that they bind to the same or overlapping sites. However, 
we cannot exclude the possibility that discodermolide and 
taxol each induce microtubule polymers to adopt different 
assembly configurations that preclude the simultaneous 
Figure 4 
binding of the two ligands, and the competition by 
discodermolide may only reflect its higher affinity and 
polymerizing potency than taxol. 
Discodermolide binding activity in viva also appears to 
reside in the microtubule network. The integrity of this 
network appears to be crucial for in vivo binding, as 
treatment with colchicine or lysis prior to addition of 
[3H]discodermolide results in total loss of binding activity, 
whereas addition of taxol upon lysis preserves the binding 
activity dramatically (Fig. 4). 
Discodermolide treatment prolongs mitosis in MG63 cells, 
presumably due to its stabilizing effect on microtubules. It 
is believed that a checkpoint monitors the integrity of 
mitotic spindles and controls cell entry into anaphase 
during mitosis [l&18]; any disruption of the spindle will 
halt the cell cycle before the metaphase-anaphase 
transition, which coincides with the degradation of 
cyclin B. Our observation of prolonged cyclin B expression 
in the presence of discodermolide (Fig. 1) is consistent 
with the molecule’s effect on microtubules (and therefore 
mitotic spindles). It has been shown that the stringency of 
the spindle formation checkpoint varies among different 
cell lines [19]. In other words, in different cell types the 
ability to survive (and exit) mitosis with disrupted spindles 
varies and is positively correlated with the cell’s ability to 
degrade cyclin B during the prolonged mitotic period [19]. 
In this case, MG63 cells are only held at M phase for 
6-12 h, rather than arrested permanently. 
As reported by ter Haar et al. [6], the concentration of 
discodermolide required to induce 50 % assembly of 
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Discodermolide binding activity in MG63 cells is found in the fraction 
containing microtubules. (a) Cells treated with 20 nM Is’Hldisco- 
dermolide were lysed and binding activity in the cell pellet as well as in 
the soluble fraction was measured as described in Materials and 
methods. Co-treatment with colchicine was carried out at 1 FM. 
Results are shown as percentage of total counts added. (b) Cells 
were lysed prior to addition of 20 nM [3H]discodermolide, with or 
without 200 nM taxol. 
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higher than its IC,, (6 nM) for inhibition of proliferation 
[3]. A similar discrepancy has also been observed for taxol 
and many other microtubule-affecting reagents. Studies on 
the effects of taxol on the dynamics of microtubules have 
led to the suggestion that inhibition of cell proliferation by 
these drugs at their lowest effective concentrations 
involves stabilization of mitotic spindle microtubule 
dynamics, inhibiting the rate and extent of shortening, 
instead of changing the amount of polymerized tubulin 
[20,21]. It is likely that discodermolide exerts its anti- 
mitotic effect by the same mechanism; by stabilizing 
microtubules, discodermolide interrupts the dynamics of 
the mitotic spindle, preventing the spindle from aligning 
the chromosomes at the metaphase plate. 
Significance 
Discodermolide is a potent immunosuppressive agent, 
which inhibits T-cell proliferation. We have shown that 
discodermolide halts the cell cycle at the metaphase-ana- 
phase transition in mitosis. Our findings suggest that 
discodermolide exerts its effect by binding and stabilizing 
mitotic spindle microtubules. Discodermolide induces the 
polymerization of purified tubulin in oitro, as does taxol, 
an antimitotic and antitumor reagent known to stabilize 
microtubules. Although they are structurally unrelated, 
discodermolide and taxol bind to mutually exclusive sites 
on the tubulin unit. Discodermolide’s binding affinity for 
microtubules is much higher than that of taxol. 
The in vivo binding activity of [3Hldiscodermolide is also 
associated with the microtubule network. Although 
micromolar concentrations of discodermolide are 
required to induce microtubule assembly in vitro, 
discodermolide inhibits cell proliferation at low 
nanomolar concentrations. Discodermolide’s cellular 
effect is probably attributable to an ability to alter mitotic 
spindle microtubule dynamics, and probably does not 
require a net increase of microtubule polymers. The fact 
that discodermolide and taxol have similar cellular 
actions, and the fact that discodermolide has higher 
potency than taxol, suggest that discodermolide could be 
an effective therapeutic agent for the treatment of cancer. 
Using discodermolide in this way will require a solution 
to the problem of insufftcient supply, however, a situation 
reminiscent of the early phase of taxol studies. 
Materials and methods 
Cell cultures 
Unless otherwise stated, MG63 cells and Swiss 3T3 cells were 
maintained at 37 “C with 5 %  CO, in RPMI-1640 and Dulbecco’s 
minimal Eagle’s medium, respectively, both containing 10 %  fetal 
bovine serum (FBS) and streptomycin/penicillin. These reagents were 
obtained from Gibco-BRL. 
Analysis of cyclin B expression 
To synchronize MG63 cells, the cells were first grown in 10 %  fetal 
bovine serum to 50-70 %  confluency. For G O  arrest, the cells were 
washed twice with serum-free medium, then incubated in media 
containing 0.2 %  FBS for 46 h. For S-phase arrest, the cells were 
incubated in regular media containing 2 m M  hydroxyurea for 24 h. 
When the synchronized cells were released from either arrest by 
changing back to regular medium, discodermolide or taxol was added 
to 100 nM. At various times cells were washed with phosphate- 
buffered saline (PBS) and lysed in sodium dodecyl sulphate (SDS) 
sample buffer. Aliquots of cell lysates equivalent in cell numbers were 
loaded on 10 46 SDS gels, separated by electrophoresis, transferred 
to a membrane and analyzed using anti-human cyclin Bl monoclonal 
antibody (Santa Cruz Biotechnology). 
Indirect immunofluorescence 
Swiss 3T3 cells were plated on coverslips and grown to 50-60 %  
confluency under normal conditions, followed by drug treatment for 
24-36 h. The cells were washed with PBS, fixed in 4 %  formaldehyde 
for 15 min, then in 100 %  methanol for 2 min. After extensive washing 
with PBS, the ceils were incubated with anti-8tubulin monoclonal 
antibody (Boehringer-Mannheim) in 3 %  BSA (bovine serum albumin) 
for 1 h, washed three times in PBS, and incubated with fluorescein- 
conjugated anti-mouse IgG antibody (Gibco-BRL) in 3 %  BSA for 
30 min. Subsequently the coverslips were washed three times in PBS, 
and mounted on slides in 20 96 glycerol saturated with 1,4-d&a- 
bicyclo[2,2,2]octane and containing 0.1 pg ml-’ propidium iodide. 
In vitro tubulin assembly and discodermolide binding 
Purified tubulin was a generous gift from Heather Deacon and Tim 
Mitchison’s laboratory. A trace amount of GTP may be present in the 
tubulin samples. Polymerization of 10 uM purified tubulin in the 
presence of 10 pM discodermolide or taxol was carried out in PEM 
buffer (80 m M  PIPES, pH 6.9, 1 m M  EGTA, 1 m M  MgCI,) at 37 “C 
and measured by turbidity change at 350 nm. To assess disco- 
dermolide binding to microtubules, 10 uM tubulin was polymerized 
with 10 FM taxol in the presence of 1 m M  GTP at 37 “C. Upon 
completion of polymerization, j3Hldiscodermolide 131 was added at 
various concentrations. Following incubation at 37 “C for 30 min, 
microtubules were sedimented in a microfuge at 14 000 rpm for 
20 min. The pellets were resuspended in scintillation fluid and 
counted. The binding efficiency was -80 %. For competition experi- 
ments, 10 p,M tubulin was polymerized in the presence of 10 FM 
j3H]discodermolide (specific activity 8 Ci mmol-‘) or [3H]taxol 
(Moravek Biochemicals, Inc., specific activity 15.7 Ci mmol-I) at 
37 “C, and various concentrations of competitors were added 
subsequently. After incubation at 37 “C for an additional 30 min, the 
microtubules were collected as above and counted. 
Discodermolide binding activity in cells 
For in viva binding assays, MG63 cells were treated with 20 nM 
j3H]discodermolide for 30-36 h. As a control, an excess of cold 
discodermolide (2 FM) was added together with the tritiated 
compound. Treated cells were washed in PBS, trypsinized, and lysed 
in lysis buffer (50 m M  Tris-HCI, pH 8.0, 150 m M  NaCI, 5 m M  EGTA, 
1 %  Triton X-l 00). After 10 min centrifugation in a microfuge, the pellet 
and supernatant were separated. The total protein content from the 
supernatant was precipitated by incubation with 100 kg ml-l 
y-globulin and 12.5 %  PEG-8000 on ice for 10 min, followed by 
centrifugation for 10 min. Both the protein pellet and the cell pellet 
were resuspended in scintillation fluid and counted. The binding 
assays were also performed in cell lysates as described above, except 
that untreated cells were lysed in lysis buffer with or without 1 $vf taxol 
prior to the addition of 13Hldiscodermolide. 
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